CD8A and neoplasm: Recently, Cronin et al. demonstrated that genetic inactivation of GCH1 significantly impairs T-cell proliferation in mature mice and humans, while enhancement of BH4 levels via GCH1 overexpression boosts the response of CD4+ and CD8+ T-cells, thereby enhancing their anti-tumor activity (Cronin et al., 2018).